Pure tone hearing thresholds and speech recognition scores in Dutch patients carrying mutations in the USH2A gene
- PMID: 12544030
- DOI: 10.1097/00129492-200301000-00013
Pure tone hearing thresholds and speech recognition scores in Dutch patients carrying mutations in the USH2A gene
Abstract
Objective: To establish the audiometric profile and speech recognition characteristics in 36 Usher IIa patients, carrying one (A) or two (B) pathogenic mutations in the gene.
Study design: Family study.
Setting: Tertiary referral center.
Patients: Thirty six Usher IIa patients from 21 Dutch families.
Methods: Ophthalmologic, vestibular, and audiometric examinations were performed on all patients. Cross-sectional analysis was performed on pure tone threshold data at 0.25 to 8 kHz and on speech phoneme recognition scores. Progression was evaluated using linear regression analysis on raw and presbyacusis corrected data.
Results: A downsloping audiogram was found, with a mean threshold slope of -9 dB per octave, that was mildly progressive, i.e., by approximately 0.5 dB per year. Individual monaural maximum phoneme recognition scores (% correct) were analyzed in 30 patients in relation to the patient's age and level of hearing impairment characterized by a pure tone average (PTA(1-4 kHz)). The speech recognition score started to deteriorate from a score of 90% at 38 years at a rate of 0.4% per year. The 90% level was attained at 69 dB hearing level (PTA(1-4 kHz)); at higher levels of impairment, the score deteriorated at a slope of 0.6% per dB hearing level. There was no significant difference between group A and B in pure tone threshold, with or without presbyacusis correction, or phoneme recognition score as related to age or PTA(1-4 kHz).
Conclusions: Patients with various mutations in have moderate to severe hearing impairment showing mild progression at approximately 0.5 dB hearing level per year.
Similar articles
-
Progression of low-frequency sensorineural hearing loss (DFNA6/14-WFS1).Arch Otolaryngol Head Neck Surg. 2003 Apr;129(4):421-6. doi: 10.1001/archotol.129.4.421. Arch Otolaryngol Head Neck Surg. 2003. PMID: 12707188
-
A combination of two truncating mutations in USH2A causes more severe and progressive hearing impairment in Usher syndrome type IIa.Hear Res. 2016 Sep;339:60-8. doi: 10.1016/j.heares.2016.06.008. Epub 2016 Jun 16. Hear Res. 2016. PMID: 27318125
-
Audiometric characteristics of a Dutch family with Muckle-Wells syndrome.Hear Res. 2011 Dec;282(1-2):243-51. doi: 10.1016/j.heares.2011.07.006. Epub 2011 Jul 23. Hear Res. 2011. PMID: 21810457
-
[Hearing Loss and Speech Recognition in the Elderly].Laryngorhinootologie. 2017 Nov;96(11):759-764. doi: 10.1055/s-0043-119388. Epub 2017 Nov 13. Laryngorhinootologie. 2017. PMID: 29132188 Review. German.
-
Autosomal dominant non-syndromal low-frequency sensorineural hearing impairment linked to chromosome 4p16 (DFNA14): statistical analysis of hearing threshold in relation to age and evaluation of vestibulo-ocular functions.Audiology. 1999 May-Jun;38(3):165-73. doi: 10.3109/00206099909073018. Audiology. 1999. PMID: 10437687 Review.
Cited by
-
Atypical and ultra-rare Usher syndrome: a review.Ophthalmic Genet. 2020 Oct;41(5):401-412. doi: 10.1080/13816810.2020.1747090. Epub 2020 May 6. Ophthalmic Genet. 2020. PMID: 32372680 Free PMC article. Review.
-
Hearing aid fitting for visual and hearing impaired patients with Usher syndrome type IIa.Clin Otolaryngol. 2017 Aug;42(4):805-814. doi: 10.1111/coa.12775. Epub 2016 Nov 6. Clin Otolaryngol. 2017. PMID: 27759911 Free PMC article.
-
Severe or Profound Sensorineural Hearing Loss Caused by Novel USH2A Variants in Korea: Potential Genotype-Phenotype Correlation.Clin Exp Otorhinolaryngol. 2020 May;13(2):113-122. doi: 10.21053/ceo.2019.00990. Epub 2019 Nov 2. Clin Exp Otorhinolaryngol. 2020. PMID: 31674169 Free PMC article.
-
Survey in to the prevalence of hearing loss in patients diagnosed with retinitis pigmentosa.Int Ophthalmol. 2004 Oct-Dec;25(5-6):277-82. doi: 10.1007/s10792-005-2035-y. Epub 2006 Mar 7. Int Ophthalmol. 2004. PMID: 16532290
-
Genetics, pathogenesis and therapeutic developments for Usher syndrome type 2.Hum Genet. 2022 Apr;141(3-4):737-758. doi: 10.1007/s00439-021-02324-w. Epub 2021 Jul 30. Hum Genet. 2022. PMID: 34331125 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous